Showing 35,225 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Global health initiatives

Ensuring that people and communities have the power to choose, to know, to thrive and to demand is the key to ending AIDS

Editor's pick
UNAIDS
27 November 2019

HIV update - 27th November 2019

November 2019
Finance & funding

UK and South Africa are chasing the US in run for top producer of HIV/AIDS related research

Editor's pick
Elsevier press release
26 November 2019
Organ transplants

HIV factor in kidney transplants: research sheds new light on risks

Editor's pick
The Conversation
26 November 2019
History of HIV & AIDS

aidsmapLIVE: World AIDS Day 2019 special Video

November 2019
Retention & linkage to care

South Africa needs to get more young people with HIV on treatment

Editor's pick
The Conversation
26 November 2019
People & personal stories

8 Months Ago, I Was Diagnosed with HIV While on PrEP

Editor's pick
TheBody
26 November 2019
Drug interactions & pharmacokinetics

Vigilance over HIV drug interactions still needed

News
26 November 2019
Religion & faith

How Churches Fight the Stigma of H.I.V.

Editor's pick
New York Times
25 November 2019
PrEP programmes & uptake

People Seeking PrEP Face Numerous Nonfinancial Roadblocks

Editor's pick
POZ
25 November 2019
Opportunistic infections

‘No benefit’ in giving HIV-exposed babies co-trimoxazole, study finds

Editor's pick
Avert
25 November 2019
Epidemiology

HIV Diagnoses Fall to Historic Low in New York City

Editor's pick
Advocate
25 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
PrEP policies & guidelines

Barring cisgender women from the Descovy trials was a bad call

Editor's pick
STAT
25 November 2019
Changing treatment

Caveat emptor: Seven things every patient should know about switching from efavirenz to dolutegravir

Editor's pick
Spotlight
25 November 2019
Epidemiology

Almost 27,000 persons with HIV in Cuba

Editor's pick
OnCuba News
25 November 2019
Government, leadership & policy

Rwanda hosting ICASA is well deserved

Editor's pick
The New Times
25 November 2019
HIV testing policies & guidelines

More Antimicrobial Prescriptions May Be Clue to Undiagnosed HIV

Editor's pick
NATAP
25 November 2019
Liver disease

Tesamorelin reduces liver fat and fibrosis progression in people with HIV and non-alcoholic fatty liver disease

News
25 November 2019
Treatment interruptions

Second case of unintended HIV transmission during HIV cure study prompts questions about PrEP provision

News
22 November 2019
PrEP programmes & uptake

Intermittent and lower-risk PrEP users may not be testing for HIV and STIs, German study finds

News
22 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
Mental & emotional health & wellbeing

PrEP users have less HIV anxiety

News
21 November 2019
HIV in the arts & media

AIDS Memorial Quilt Is Returning Home To San Francisco

Editor's pick
NPR
21 November 2019